AstraZeneca leukemia drug Calquence gets USFDA okay Medical Dialogues Bureau24 Nov 2019 10:00 AM ISTNew Delhi: AstraZeneca said late on Thursday that the U.S. Food and Drug Administration (FDA) had given its go-ahead for the company's Calquence drug...
BeiGene gets USFDA approval for lymphoma drug Brukinsa Medical Dialogues Bureau17 Nov 2019 9:20 AM ISTBeiGene tested the treatment, Brukinsa, in 118 patients with mantle cell lymphoma enrolled in two studies. About three-quarters were Asian, 21%...
AstraZeneca CKD anaemia drug Roxadustat shows increased haemoglobin levels in Phase 3 trial Medical Dialogues Bureau9 Nov 2019 9:15 AM ISTNew Delhi: AstraZeneca recently presented detailed results from the Phase III OLYMPUS and ROCKIES trials showing that Roxadustat significantly...
AstraZeneca sells European rights for schizophrenia drug Seroquel, Seroquel XR for USD 178 million Farhat Nasim30 Oct 2019 5:25 PM ISTThe treatment, Seroquel, and another version, Seroquel XR, have lost patent protection in Europe and Russia, AstraZeneca said. The drug variants are...
GSK ovarian cancer drug Zejula gets USFDA nod for wider use Medical Dialogues Bureau24 Oct 2019 10:00 AM ISTZejula was the lead compound of U.S. cancer specialist Tesaro, which GSK acquired for $5.1 billion last year. Zejula brought in sales of 57 million...
AstraZeneca India bags DCGI marketing nod for QTERN-once-daily anti-diabetes drug Medical Dialogues Bureau27 Sept 2019 11:54 AM IST26 September 2019: AstraZeneca Pharma India Limited (AstraZeneca India) announced that it has received Import & Market permission for QTERN®...
Mylan launches generic version of Faslodex Injection to treat breast cancer Medical Dialogues Bureau19 Sept 2019 9:35 AM ISTNew Delhi: Mylan N.V. recently announced the U.S. launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per single-dose prefilled syringe, a generic...
Sanofi revival depends on outsider with nose for big drugs: Report Medical Dialogues Bureau3 Sept 2019 8:58 AM ISTDefining Sanofi's ambitions in the cutting-edge field of gene therapies and figuring out whether to hold on to consumer health brands are among other...
Delhi HC given Green Signal to Natco Pharma for generic of Novartis cancer drug Ceritinib Farhat Nasim1 Sept 2019 2:33 PM ISTNew Delhi: In a major relief to Natco, the Delhi High Court has lifted a ban on Natco Pharma from manufacturing fresh stock of on-small cell lung...
GSK drug Zejula helps ovarian cancer patients live longer in late-stage study Medical Dialogues Bureau16 July 2019 9:26 AM ISTGSK bought the drug when it acquired U.S. cancer specialist Tesaro for $5.1 billion in December and Zejula is already approved for certain ovarian...
GSK pharma head flags need for speed in high-pressure drug market Medical Dialogues Bureau18 Jun 2019 2:06 PM ISTLONDON: Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at...
Merck wins USFDA nod for blockbuster drug Keytruda to treat head, neck cancer Medical Dialogues Bureau12 Jun 2019 9:50 AM ISTThe approval is based on results from a late-stage trial, where Keytruda showed a significant improvement in overall survival in cancer patients,...
